A Randomised, Double-Blind, French Multi-Centre Study, to Evaluate the Efficacy and Tolerance, in Comparison With Placebo, of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults.

Trial Profile

A Randomised, Double-Blind, French Multi-Centre Study, to Evaluate the Efficacy and Tolerance, in Comparison With Placebo, of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Triamcinolone (Primary)
  • Indications Rhinitis
  • Focus Therapeutic Use
  • Acronyms RhiCNANI
  • Sponsors Sanofi
  • Most Recent Events

    • 22 Oct 2008 Actual patient number (77) added as reported by ClinicalTrials.gov.
    • 22 Oct 2008 Planned end date changed from 1 Aug 2007 to 1 Apr 2007.as reported by ClinicalTrials.gov.
    • 05 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top